Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
IMNP > SEC Filings for IMNP > Form 8-K/A on 30-Oct-2013All Recent SEC Filings

Show all filings for IMMUNE PHARMACEUTICALS INC

Form 8-K/A for IMMUNE PHARMACEUTICALS INC


30-Oct-2013

Financial Statements and Exhibits


Item 9.01 Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired.

The following historical financial statements of Immune are included in this report:

(i) Unaudited Consolidated balance sheets as of June 30, 2013 and December 31, 2012, consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2013 and 2012 and for the cumulative period from July 11, 2010 (date of inception) through June 30, 2013, the consolidated statement of stockholders' deficit for the cumulative period from July 11, 2010 (date of inception) through June 30, 2013, the consolidated statements of cash flows for the six months ended June, 2013 and 2012 and for the cumulative period from July 11, 2010 (date of inception) through June 30, 2013.

(ii) Audited Consolidated balance sheets as of December 31, 2012 and 2011, and the related consolidated statements of operations and comprehensive loss, changes in shareholders' equity, and cash flows for each of the years in the two-year period ended December 31, 2012 and for the cumulative period from July 11, 2010 (date of inception) through December 31, 2012.

(b) Pro Forma Financial Information.

The following unaudited pro forma consolidated financial statements giving effect to the merger of EpiCept and Immune, completed August 25, 2013 (as of June 30, 2013) are included in this report:

(i) Unaudited pro forma condensed consolidated balance sheet as of June 30, 2013 and unaudited pro forma condensed consolidated statement of operations for the six months ended June 30, 2013.

(ii) Unaudited pro forma condensed consolidated statement of operations for the year ended December 31, 2012.

(c) Exhibits.

23.1 Consent of EisnerAmper LLP, Independent Registered Public Accounting Firm.

99.1 Unaudited Consolidated balance sheets as of June 30, 2013 and December 31, 2012, consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2013 and 2012 and for the cumulative period from July 11, 2010 (date of inception) through June 30, 2013, the consolidated statement of stockholders' deficit for the cumulative period from July 11, 2010 (date of inception) through June 30, 2013, the consolidated statements of cash flows for the six months ended June, 2013 and 2012 and for the cumulative period from July 11, 2010 (date of inception) through June 30, 2013.

99.2 Audited Consolidated balance sheets as of December 31, 2012 and 2011, and the related consolidated statements of operations and comprehensive loss, changes in shareholders' equity, and cash flows for each of the years in the two-year period ended December 31, 2012 and for the cumulative period from July 11, 2010 (date of inception) through December 31, 2012.

99.3 Unaudited pro forma condensed consolidated balance sheet as of June 30, 2013 and unaudited pro forma condensed consolidated statement of operations for the six months ended June 30, 2013 and unaudited pro forma condensed consolidated statement of operations for the year ended December 31, 2012.


Top of the Form

  Add IMNP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for IMNP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.